Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard

[1] Ahmed HU(2017)Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Lancet 389 815-822

[2] El-Shater Bosaily A(2014)Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis Am J Roentgenol 202 343-351

[3] Brown LC(2012)ESUR prostate MR guidelines 2012 Eur Radiol 22 746-757

[4] Gabe R(2016)Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR J Urol 196 1613-1618

[5] Kaplan R(2016)Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: a Cancer Care Ontario clinical practice guideline Can Urol Assoc J 10 332-1277

[6] Parmar MK(2017)Risk stratification among men with prostate imaging reporting and data system version 2 category 3 transition zone lesions: is biopsy always necessary? Am J Roentgenol 209 1272-356

[7] Collaco-Moraes Y(2017)Risk of clinically significant prostate cancer associated with prostate imaging reporting and data system category 3 (equivocal) lesions identified on multiparametric prostate MRI Am J Roentgenol 285 343-40

[8] Ward K(2017)The current state of MR imaging-targeted biopsy techniques for detection of prostate cancer Radiology 69 16-934

[9] Hindley RG(2016)PI-RADS Prostate imaging—reporting and data system: 2015, version 2 Eur Urol 10 925-1163

[10] Freeman A(2015)Open-source image registration for MRI–TRUS fusion-guided prostate interventions Int J Comput Assist Radiol Surg 42 1153-7

[1] Ahmed HU(2017)Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Lancet 389 815-822

[2] El-Shater Bosaily A(2014)Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis Am J Roentgenol 202 343-351

[3] Brown LC(2012)ESUR prostate MR guidelines 2012 Eur Radiol 22 746-757

[4] Gabe R(2016)Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR J Urol 196 1613-1618

[5] Kaplan R(2016)Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: a Cancer Care Ontario clinical practice guideline Can Urol Assoc J 10 332-1277

[6] Parmar MK(2017)Risk stratification among men with prostate imaging reporting and data system version 2 category 3 transition zone lesions: is biopsy always necessary? Am J Roentgenol 209 1272-356

[7] Collaco-Moraes Y(2017)Risk of clinically significant prostate cancer associated with prostate imaging reporting and data system category 3 (equivocal) lesions identified on multiparametric prostate MRI Am J Roentgenol 285 343-40

[8] Ward K(2017)The current state of MR imaging-targeted biopsy techniques for detection of prostate cancer Radiology 69 16-934

[9] Hindley RG(2016)PI-RADS Prostate imaging—reporting and data system: 2015, version 2 Eur Urol 10 925-1163

[10] Freeman A(2015)Open-source image registration for MRI–TRUS fusion-guided prostate interventions Int J Comput Assist Radiol Surg 42 1153-7